UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Common Stock Held in Treasury	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021			95,746,975		107,820
Beginning balance at Dec. 31, 2021	$ 709,624	$ (198)	$ 68	$ 916,578	$ (897)	$ (206,218)	$ (198)	$ 93
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,112
Common stock issued for exercise of employee stock options (in shares)			8,486
Common stock issued for exercise of employee stock options	80			80
Issuance of restricted shares, net of forfeitures and vesting (in shares)			533,095
Issuance of restricted shares, net of forfeitures and vestings	0		$ 5	(5)
Stock-based compensation	5,108			5,108
Net income	6,236					6,236
Foreign currency translation adjustment, net of tax				(8)				283
Foreign currency translation adjustment, net of tax	275
Ending Balance (in shares) at Mar. 31, 2022			96,289,668		107,820
Ending Balance at Mar. 31, 2022	721,125		$ 73	921,753	$ (897)	(200,180)		376
Beginning balance (in shares) at Dec. 31, 2021			95,746,975		107,820
Beginning balance at Dec. 31, 2021	709,624	$ (198)	$ 68	916,578	$ (897)	(206,218)	$ (198)	93
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	17,807
Unrealized gain (loss) on hedged transactions, net of tax	0
Foreign currency translation adjustment, net of tax	(3,200)
Ending Balance (in shares) at Jun. 30, 2022			96,410,267		107,820
Ending Balance at Jun. 30, 2022	735,946		$ 73	928,486	$ (897)	(188,609)		(3,107)
Beginning balance (in shares) at Mar. 31, 2022			96,289,668		107,820
Beginning balance at Mar. 31, 2022	721,125		$ 73	921,753	$ (897)	(200,180)		376
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			1,812
Common stock issued for exercise of employee stock options (in shares)			76,399
Common stock issued for exercise of employee stock options	734			734
Issuance of restricted shares, net of forfeitures and vesting (in shares)			42,388
Stock-based compensation	6,023			6,023
Net income	11,571					11,571
Unrealized gain (loss) on hedged transactions, net of tax	0
Foreign currency translation adjustment, net of tax	(3,483)			(24)				(3,483)
Foreign currency translation adjustment, net of tax	(3,507)
Ending Balance (in shares) at Jun. 30, 2022			96,410,267		107,820
Ending Balance at Jun. 30, 2022	735,946		$ 73	928,486	$ (897)	(188,609)		(3,107)
Beginning balance (in shares) at Dec. 31, 2022			96,717,883		1,047,237
Beginning balance at Dec. 31, 2022	736,646		$ 76	942,789	$ (14,859)	(186,448)		(4,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			4,567
Issuance of restricted shares, net of forfeitures and vesting (in shares)			1,894,310
Issuance of restricted shares, net of forfeitures and vestings	0		$ 19	(19)
Repurchases of common stock (in shares)			493,926		493,926
Repurchases of common stock	(7,712)				$ (7,712)
Shares withheld to cover restricted share vestings tax (in shares)			37,128		37,128
Shares withheld to cover restricted share vestings tax	(487)				$ (487)
Stock-based compensation	8,043			8,043
Net income	591					591
Unrealized gain (loss) on hedged transactions, net of tax	(5,159)							(5,159)
Foreign currency translation adjustment, net of tax	682							682
Ending Balance (in shares) at Mar. 31, 2023			98,085,706		1,578,291
Ending Balance at Mar. 31, 2023	732,604		$ 95	950,813	$ (23,058)	(185,857)		(9,389)
Beginning balance (in shares) at Dec. 31, 2022			96,717,883		1,047,237
Beginning balance at Dec. 31, 2022	$ 736,646		$ 76	942,789	$ (14,859)	(186,448)		(4,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of common stock (in shares)	1,959,819
Repurchases of common stock	$ (25,300)
Net income	914
Unrealized gain (loss) on hedged transactions, net of tax	(408)
Foreign currency translation adjustment, net of tax	1,637
Ending Balance (in shares) at Jun. 30, 2023			96,758,662		3,051,365
Ending Balance at Jun. 30, 2023	730,887		$ 96	960,781	$ (40,773)	(185,534)		(3,683)
Beginning balance (in shares) at Mar. 31, 2023			98,085,706		1,578,291
Beginning balance at Mar. 31, 2023	732,604		$ 95	950,813	$ (23,058)	(185,857)		(9,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)			2,363
Common stock issued for exercise of employee stock options (in shares)			63,336
Common stock issued for exercise of employee stock options	611			611
Issuance of restricted shares, net of forfeitures and vesting (in shares)			80,331
Issuance of restricted shares, net of forfeitures and vestings	$ 0		$ 1	(1)
Repurchases of common stock (in shares)	1,465,893		1,465,893		1,465,893
Repurchases of common stock	$ (17,630)				$ (17,630)
Shares withheld to cover restricted share vestings tax (in shares)			7,181		7,181
Shares withheld to cover restricted share vestings tax	(85)				$ (85)
Stock-based compensation	9,358			9,358
Net income	323					323
Unrealized gain (loss) on hedged transactions, net of tax	4,751							4,751
Foreign currency translation adjustment, net of tax	955							955
Ending Balance (in shares) at Jun. 30, 2023			96,758,662		3,051,365
Ending Balance at Jun. 30, 2023	$ 730,887		$ 96	$ 960,781	$ (40,773)	$ (185,534)		$ (3,683)